NATALIE SCARDINO: Open Payments
NPI 1114262474 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 39 payments from 16 companies in 2025. Trend: 2023 $897 · 2024 $733 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $109 |
| ABBVIE INC. | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Lundbeck LLC | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Novo Nordisk Inc | 3 | $47 |
| PFIZER INC. | 2 | $43 |
| Almatica Pharma LLC | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
Products named: JARDIANCE, MOUNJARO, REXULTI, VRAYLAR, AIRSUPRA, LOREEV XR, SPRAVATO, Ozempic.
Industry payments across OK — which companies pay providers there.
